Carbon nanomaterials reinforced poly(lactic-co-glycolic acid) composites for bone tissue engineering

Poly (lactic-co-glycolic)/nanostructured merwinite porous composites for bone tissue engineering: II. structural and in vitro characterization

Several characteristics of a novel PLGA/Merwinite scaffold were examined in the present study to evaluate the possible applications in bone tissue regeneration. Physical and mechanical properties, as well as degradation behavior and in vitro bioactivity of porous scaffolds produced by solvent casting and particle leaching technique were also characterized. Results showed that incorporation of m...

An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering

Poly(lactic-co-glycolic) acid (PLGA) has attracted considerable interest as a base material for biomedical applications due to its: (i) biocompatibility; (ii) tailored biodegradation rate (depending on the molecular weight and copolymer ratio); (iii) approval for clinical use in humans by the U.S. Food and Drug Administration (FDA); (iv) potential to modify surface properties to provide better ...

New Polylactic Acid Composites Reinforced with Artichoke Fibers

In this work, artichoke fibers were used for the first time to prepare poly(lactic acid) (PLA)-based biocomposites. In particular, two PLA/artichoke composites with the same fiber loading (10% w/w) were prepared by the film-stacking method: the first one (UNID) reinforced with unidirectional long artichoke fibers, the second one (RANDOM) reinforced by randomly-oriented long artichoke fibers. Bo...

Poly(lactic acid) (PLA) Nanofibers for Bone Tissue Engineering

Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid

BACKGROUND Nanoparticles fabricated from the biodegradable and biocompatible polymer, polylactic-co-glycolic acid (PLGA), are the most intensively investigated polymers for drug delivery systems. The objective of this study was to explore fully the development of a PLGA nanoparticle drug delivery system for alternative preparation of a commercial formulation. In our nanoparticle fabrication, ou...